AZD8931, reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%)
-
Catalog number
SM-101090-25
-
Price
Please ask
-
Size
25 mg
-
-
Stock availability
Available
-
Category
Custom Service
-
Antibody type
N/A
-
Antibody host
N/A
-
Antibody conjugate
N/A
-
Technical datasheet
Contact Gentaur to request the datasheet or ask our specialists for more information.
-
Notes
The AZD8931, reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%) is manufactured for Research Use Only or for diagnostics purposes.
-
-
Description
Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.
-
Gene target
-
Short name
AZD8931, reversible competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%)
-
Species
N/A
-
Alternative name
AZD8931, reversible and competitive suppressor on Her2/v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)/v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (mol wt 473; >98%)
-
Alternative to gene target
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian), c-erbB-3 and c-erbB3 and ErbB-3 and erbB3-S and HER3 and LCCS2 and MDA-BF-1 and p180-ErbB3 and p45-sErbB3 and p85-sErbB3, ERBB3 and IDBG-39824 and ENSG00000065361 and 2065, transferase activity, Extracellular, Erbb3 and IDBG-197943 and ENSMUSG00000018166 and 13867, ERBB3 and IDBG-636302 and ENSBTAG00000010444 and 785655
-
Product images
Similar products
